EC
EcoR1 Capital’s Dyne Therapeutics DYN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-555,644
| Closed | -$13.1M | – | 49 |
|
|
2024
Q4 | $13.1M | Hold |
555,644
| – | – | 0.49% | 34 |
|
|
2024
Q3 | $20M | Buy |
555,644
+128,605
| +30% | +$4.62M | 0.68% | 34 |
|
|
2024
Q2 | $15.1M | Hold |
427,039
| – | – | 0.46% | 39 |
|
|
2024
Q1 | $12.1M | Buy |
+427,039
| New | +$12.1M | 0.31% | 41 |
|
|
2023
Q3 | – | Sell |
-798,701
| Closed | -$8.99M | – | 51 |
|
|
2023
Q2 | $8.99M | Sell |
798,701
-1,523,683
| -66% | -$17.1M | 0.22% | 34 |
|
|
2023
Q1 | $26.8M | Hold |
2,322,384
| – | – | 0.86% | 17 |
|
|
2022
Q4 | $26.9M | Buy |
+2,322,384
| New | +$26.9M | 0.82% | 24 |
|
|
2022
Q3 | – | Sell |
-215,000
| Closed | -$1.48M | – | 79 |
|
|
2022
Q2 | $1.48M | Hold |
215,000
| – | – | 0.05% | 61 |
|
|
2022
Q1 | $2.07M | Hold |
215,000
| – | – | 0.06% | 64 |
|
|
2021
Q4 | $2.56M | Hold |
215,000
| – | – | 0.08% | 54 |
|
|
2021
Q3 | $3.57M | Hold |
215,000
| – | – | 0.12% | 46 |
|
|
2021
Q2 | $4.52M | Hold |
215,000
| – | – | 0.17% | 44 |
|
|
2021
Q1 | $3.34M | Hold |
215,000
| – | – | 0.15% | 46 |
|
|
2020
Q4 | $4.52M | Hold |
215,000
| – | – | 0.24% | 42 |
|
|
2020
Q3 | $4.34M | Buy |
+215,000
| New | +$4.34M | 0.31% | 31 |
|